Kapilbhai Hasmukhbhai Chandarana, a promoter group member, acquired 10,000 equity shares of Aptus Pharma Limited on May 11, 2026.
The acquisition increased his total holding from 775,000 shares (11.30%) to 785,000 shares (11.44%) of the company's voting capital.
Transaction was executed off-market and disclosed under SEBI SAST Regulation 29(2) requirements.
Company has total equity share capital of 6,860,000 shares of ₹10 each, unchanged post-transaction.